Page last updated: 2024-10-30

metformin and Diabetes Insipidus and Mellitus with Optic Atrophy and Deafness

metformin has been researched along with Diabetes Insipidus and Mellitus with Optic Atrophy and Deafness in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hofmann, M1
Boehmer, H1
Zumbach, M1
Borcea, V1
Grauer, A1
Kasperk, C1
Heilmann, P1
Ziegler, R1
Wahl, P1
Nawroth, PP1

Reviews

1 review available for metformin and Diabetes Insipidus and Mellitus with Optic Atrophy and Deafness

ArticleYear
[The Wolfram syndrome: diabetes mellitus, hypacusis, optic atrophy and short stature in STH deficiency].
    Deutsche medizinische Wochenschrift (1946), 1997, Jan-24, Volume: 122, Issue:4

    Topics: Adult; Drug Therapy, Combination; Glyburide; Growth Disorders; Human Growth Hormone; Humans; Hypogly

1997